Press release archive - GSK
24 September 2024. GSK’s Menveo meningococcal vaccine in new single-vial, fully liquid presentation receives positive European CHMP opinion.
GSK announces cap of $35 per month on U.S. patient out-of …
GSK today announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all of its asthma and chronic obstructive pulmonary disease (COPD) medicines,* the most prescribed portfolio of inhalers in the U.S. GSK is taking this action as part of its longstanding commitment to improving access to respiratory medici...
Press releases | GSK US
October 08 2024. GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV seasons. GSK will continue to provide data on longer-term follow-up to help recommending bodies determine future revaccination schedules. Download (PDF, 274.3KB) September 18 2024.
GlaxoSmithKline News | GSK News - NewsNow
NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications.
GSK plc (GSK) Latest Stock News & Headlines - Yahoo Finance
Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.
GSK's experimental drug shows promise in reducing severe …
May 21 (Reuters) - GSK's (GSK.L) experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to...
GSK Sues Moderna for US Patent Infringement Over COVID, RSV ... - U.S. News
Oct 15, 2024 · (Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its...
GSK says tests indicate antibody drug works against Omicron
Dec 2, 2021 · Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the...
GSK raises profit outlook on strong vaccine, HIV drug sales
May 1 (Reuters) - GSK (GSK.L) raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV medicines, though it expects sales growth to...
GlaxoSmithKline PLC. - The New York Times
News about GlaxoSmithKline PLC., including commentary and archival articles published in The New York Times.